UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000035541 |
|---|---|
| Receipt number | R000040497 |
| Scientific Title | A study on the relevance between biological barrier and morbidity of infection. |
| Date of disclosure of the study information | 2019/01/16 |
| Last modified on | 2019/07/17 12:29:11 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A study on the relevance between biological barrier and morbidity of infection.
Acronym
A study on the relevance between biological barrier and morbidity of infection.
Scientific Title
A study on the relevance between biological barrier and morbidity of infection.
Scientific Title:Acronym
A study on the relevance between biological barrier and morbidity of infection.
Region
| Japan |
Condition
Condition
Healthy adults
Classification by specialty
| Infectious disease | Dermatology | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The aim of this study is to reveal the effect of biological barrier on morbidity of infection in winter when infection are prevalent
Basic objectives2
Others
Basic objectives -Others
General survey to reveal the relevance between biological barrier and morbidity of infection.
Trial characteristics_1
Exploratory
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Indicators of biological barrier;
ex) activity of immune cells, body temperature, antiviral activity
Key secondary outcomes
Questionnaire survey about lifestyle, rate of infection diseases
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 49 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1) Japanese.
Age >=20 and <=49 years.
2) Informed consent provided
3) Able to follow the instructions of the study team
Key exclusion criteria
1) Serious disorder
2) Regular hospital visit and medication intended to cure
3) Women who are or may be pregnant and who are lactating
4) Subjects judged by the investigator/project leader to be ineligible for other reasons
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Takuya Mori |
Organization
Kao Corporation
Division name
Biological Science Research
Zip code
Address
2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN
TEL
0285-68-7769
mori.takuya@kao.com
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yoshitaka Koga |
Organization
Kao Corporation
Division name
Biological Science Research
Zip code
Address
2606, Akabane, Ichikai-machi, haga-gun, Tochigi, 321-3497, JAPAN
TEL
0285-68-7613
Homepage URL
koga.yoshitaka@kao.com
Sponsor or person
Institute
Kao Corporation
Institute
Department
Personal name
Funding Source
Organization
Kao Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
花王株式会社（栃木県）
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 01 | Month | 16 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 12 | Month | 19 | Day |
Date of IRB
| 2018 | Year | 12 | Month | 19 | Day |
Anticipated trial start date
| 2019 | Year | 01 | Month | 16 | Day |
Last follow-up date
| 2019 | Year | 06 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
General survey to reveal the relevance between biological barrier and morbidity of infection.
Management information
Registered date
| 2019 | Year | 01 | Month | 15 | Day |
Last modified on
| 2019 | Year | 07 | Month | 17 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040497
